Cargando…
Advances in the development of antivirals for rotavirus infection
Rotavirus (RV) causes 200,000 deaths per year and imposes a serious burden to public health and livestock farming worldwide. Currently, rehydration (oral and intravenous) remains the main strategy for the treatment of rotavirus gastroenteritis (RVGE), and no specific drugs are available. This review...
Autores principales: | Jiang, Lin, Tang, Ao, Song, Lihua, Tong, Yigang, Fan, Huahao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063883/ https://www.ncbi.nlm.nih.gov/pubmed/37006293 http://dx.doi.org/10.3389/fimmu.2023.1041149 |
Ejemplares similares
-
Molnupiravir and Its Antiviral Activity Against COVID-19
por: Tian, Lili, et al.
Publicado: (2022) -
Advances in the Development of Antiviral Compounds for Rotavirus Infections
por: Tohmé, María Julieta, et al.
Publicado: (2021) -
Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
por: Chen, Yangzhen, et al.
Publicado: (2022) -
Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection
por: Villena, Julio, et al.
Publicado: (2016) -
Overview of Breastfeeding Under COVID-19 Pandemic
por: Pang, Zehan, et al.
Publicado: (2022)